1917 West 4th Avenue
Vancouver, BC V6J 1M7
Industry: Medical Care Facilities
Full Time Employees:
|Mr. Peter Nguyen C.A., C.P.A.||CFO & Director||14.6k||N/A||1987|
|Mr. Adam Deffett C.F.A.||Interim CEO, VP of Capital Markets & Communications||N/A||N/A||N/A|
|Dr. Mark Kimmins||Chief Medical Officer & Chairman of Medical Advisory Board||N/A||N/A||N/A|
|Ms. Najla Guthrie||Chief Research Officer||N/A||N/A||N/A|
|Mr. Keith White||Pres of Clinic Operations||N/A||N/A||N/A|
KetamineOne Capital Limited, a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as Myconic Capital Corp. and changed its name to KetamineOne Capital Limited in June 2021. KetamineOne Capital Limited was founded in 2017 and is headquartered in Vancouver, Canada.
KetamineOne Capital Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.